ArticleMolecular cancer therapeutics2017

Inhibition of AKR1C3 Activation Overcomes Resistance to Abiraterone in Advanced Prostate Cancer.

Chengfei Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.